COMMUNIQUÉ DE PRESSE

Botanic Tonics Responds to CBS’ '60 Minutes': Natural Kratom Leaf and Concentrated Synthetic 7-OH Are Different Products

BROKEN ARROW, OK, November 18th, 2026, FinanceWire


The federal record draws the distinction the segment left out

BROKEN ARROW, OK, November 17, 2026 (EZ Newswire) -- Botanic Tonics today responded to Sunday’s "60 Minutes" segment on kratom, which presented natural kratom leaf and concentrated synthetic 7-OH as a single category and placed accounts involving concentrated synthetic 7-OH alongside feel free CLASSIC. This release sets out the facts the segment left out.

The Segment Treated Two Different Products as One

The evidence was personal accounts

Much of the segment rested on personal accounts and interviewee characterizations rather than data that separates the products. It did not feature a single consumer of natural kratom leaf with a positive experience, although millions of Americans consume it.

Federal agencies separate the products

HHS describes the products it is scheduling as concentrated or enhanced opioid products and separates them from natural botanical kratom. The federal record says so repeatedly:

  • The Justice Department’s October update states that HHS’s analysis confirms 7-OH occurs naturally in botanical kratom at relatively low levels.
  • HHS’s Oct. 9 recommendation is designed to target concentrated or chemically altered products while distinguishing them from natural botanical kratom.
  • The DEA’s temporary scheduling action does not apply to botanical kratom products that contain naturally occurring 7-OH below the specified threshold.
  • In July 2025, HHS said the FDA’s action “is not focused on natural kratom leaf products.”

What feel free CLASSIC is made with

feel free CLASSIC is made with noble kava root and natural kratom leaf. It is not a concentrated synthetic 7-OH product, and natural kratom leaf contains only trace amounts of naturally occurring 7-OH. Botanic Tonics has long supported federal action against concentrated synthetic 7-OH and commended the DEA’s action in August.

Mixed Numbers and Anonymized Data Sets Cannot Speak for Natural Kratom Leaf

The segment applied national figures that never identify which product was involved

The segment cited more than 5,000 kratom-involved overdose deaths since 2020. That figure combines cases from across the country and counts any death in which kratom was present, regardless of product form. It cannot be tied to a specific product or to a particular type of natural kratom leaf, and the segment drew that connection anyway. Linking an aggregate total to feel free CLASSIC is a leap the data cannot support.

CDC overdose data separates kratom detected in post-mortem testing from kratom listed as a cause of death. A CDC analysis of overdose deaths in 27 states found that fentanyl or fentanyl analogs were also listed as a cause of death in 56% of kratom-involved deaths, that toxicology detected multiple substances for almost all decedents, and that kratom was the only substance detected in just seven of 152 deaths in which it was found. A Washington Post review of 2020 through 2022 data likewise found that the vast majority of cases involving kratom also involved other substances. State health departments report that their data cannot identify which specific forms or compounds are involved. The risk federal and state health agencies describe sits with concentrated products: the FDA has linked higher levels of 7-OH in synthetically enhanced products to greater risk of overdose, physical dependence, and withdrawal, and researchers at the University of Washington note that 7-OH is increasingly sold as a stand-alone and more potent product.

A single total cannot tell viewers how many cases involved natural kratom leaf, adulterated products, multiple substances, or concentrated synthetic 7-OH. Post-mortem testing that detects mitragynine cannot show whether it came from natural leaf, an extract, or a concentrate, and the segment did not identify a single death established as caused by natural kratom leaf. Botanic Tonics calls for overdose data to be reported by product type, so the public can see where the risk comes from.

What the Research Shows

A peer-reviewed study of feel free CLASSIC

feel free CLASSIC itself has been studied in people. A peer-reviewed safety study published in Cureus [1] in December 2024 and registered as ISRCTN17198496 tested the product in healthy adults ages 21 to 55. Participants consumed servings over six consecutive days in each of four periods, with a randomized, double-blind, placebo-controlled crossover comparison at the lowest serving and open-label periods at higher servings. Forty participants entered each period.

  • No serious adverse events or deaths were reported.
  • No participant discontinued because of an adverse event.
  • Investigators judged none of the vital sign changes clinically significant.
  • Withdrawal scores on the Clinical Opiate Withdrawal Scale (COWS) stayed below the threshold for mild withdrawal.
  • Each 15 mL serving contained 12.5 mg of mitragynine and less than 0.05 mg of 7-OH.

An FDA-commissioned study of natural kratom leaf

The FDA has also studied natural kratom leaf [2]. The agency commissioned a pilot single ascending dose study with a placebo group, conducted under an Investigational New Drug application. Five cohorts of eight healthy adults each took 1, 3, 8, 10, or 12 grams of encapsulated raw kratom leaf, with two participants per cohort receiving placebo. Preliminary results presented by an FDA pharmacologist in February 2024 reported no serious adverse events.

A growing body of research

These studies are part of a broader body of research. The Global Kratom Coalition [3] catalogs 18 peer-reviewed human studies on kratom, including controlled clinical trials, pharmacokinetic and medication-interaction studies, and observational clinical assessments. Annual kratom publications have grown from roughly 20 in 2016 to more than 130 by 2024. Botanic Tonics’ review of the clinical literature finds that all clinical studies to date used natural kratom leaf and powder, and none exist for extracts, concentrates, or synthetic compounds.

Every Panel of the Bottle Is Built to Inform

Consumer safety sits at the center of everything Botanic Tonics does, from how the company sources its ingredients to how it tests its products, educates consumers, and shares information openly. The feel free CLASSIC label is guided by the science and Botanic Tonics’ own clinical research.

Front of pack

The front of the package states “Can be habit forming” and “Consume responsibly” and carries a statement that the product is for adults 21 and older only.

Sides and back

Clear serving lines run along the sides of the bottle, so the serving size is visible however the bottle is held. The back of the bottle reinforces the serving limit and gives guidance on maximum servings per day. A QR code connects consumers to more information about the product and the research behind it.

Warnings

The label states that the product can be habit-forming and can be harmful if not consumed as directed. It advises against consuming the product with a history of substance abuse or with excessive alcohol, and notes that it can interact with certain medications, so consumers should consult a health care provider.

Third-party label research

Botanic Tonics commissioned a third-party contract research organization to test whether consumers understand the label as intended. In a small pilot study of 1-hour interviews conducted in July 2026, 11 adult consumers, including current kratom consumers and people interested in trying kratom, examined a feel free bottle for the first time.

  • The “Can be habit forming. Consume responsibly” statement on the front was among the most noticed on the bottle, and many participants saw the 21-and-older statement without being prompted.
  • All of the current kratom consumers understood the serving instructions and the importance of consuming as directed, and most participants who had not tried kratom said they would start with less than the directed serving.
  • Participants said the warnings communicated a serious product and that the level of detail showed the company acting responsibly.
  • Current kratom consumers described the bottle as more professional than the kratom products they consume today.

The research was designed to inform further label improvements.

Botanic Tonics’ Position

Consumers deserve to know what is in a product and what the evidence says about it. Natural kratom leaf and concentrated synthetic 7-OH are different products with different risk profiles, and the federal agencies that have addressed them draw that line. Treating them as one category confuses the public and makes it harder to protect people from the products that cause the most harm.

As feel free CLASSIC reaches more retailers and more adult consumers, Botanic Tonics is growing in a transparent and responsible way, with clear labeling that supports informed choices. Botanic Tonics leads the industry in consumer education and transparency and will continue to work with regulators, researchers, and public health officials.

Supporting Sources

[1] Peer-reviewed clinical safety study (December 2024): “The Safety of Multiple-Dose Liquid Blend Containing Kava and Kratom in Healthy Adults,” Cureus (ISRCTN17198496)

[2] FDA-commissioned pilot study (February 2024): Preliminary results presentation

[3] Human clinical trials catalog: Global Kratom Coalition, “18 Human Clinical Trials”

About Botanic Tonics

Botanic Tonics is the leader in botanical supplements. Founded in 2020 and headquartered in Broken Arrow, Oklahoma, the company's feel free® product line harnesses the wisdom of ancient botanical traditions to support energy, focus, and mood. Its flagship product, feel free® CLASSIC, combines noble kava root and natural kratom leaf in a formulation that contains no synthetic ingredients, alcohol, or chemical extracts and is intended for responsible consumption by adults 21 and older. Its KavaMaté product delivers botanical pairings that provide sustained, grounded energy without the jitters associated with artificial energy drinks. With hundreds of millions of servings sold, feel free® CLASSIC is produced in accordance with strict manufacturing and quality standards, supported by independent batch testing and peer-reviewed research. Botanic Tonics’ products are manufactured in an FDA-registered, cGMP-certified facility and undergo multiple tests for consistency and safety. Botanic Tonics continues to lead the energy and supplement category in education and transparency through extensive consumer education. Learn more at botanictonics.com.

Disclaimer

The statements in this press release have not been evaluated by the U.S. Food and Drug Administration. The products referenced are not intended to diagnose, treat, cure, or prevent any disease. This announcement is provided for informational purposes only and does not constitute medical advice.

Warning and Caution

feel free CLASSIC can be habit-forming. Consume responsibly. For adults 21 years of age and older only. Do not exceed one serving (half a bottle) at any one time, and do not exceed two servings (one bottle) in a 24-hour period. feel free CLASSIC contains kratom leaf, which, like nicotine and alcohol, can become habit-forming and harmful to your health if consumed irresponsibly. DO NOT USE if you have a history of substance abuse. May interact with certain medications — consult a licensed, qualified health care professional before use. Do not consume with excessive alcohol. Not intended for individuals sensitive to active ingredients or women who are pregnant, nursing, or trying to become pregnant. For more information, visit the Botanic Tonics Consumer Education page.

Media Contact

Botanic Tonics

media@botanictonics.com

SOURCE: Botanic Tonics




Disclaimer. This is a paid press release.